SEC Form 4 · accession 0001017832-26-000002
Bioventus Inc. · BVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin P Sutter
Director · 10% Owner
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001665988
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 2, 2026 | M | 32,282 | $0.00 | A | 117,523 | D | |
| Class A Common StockF1 | holding | — | — | — | 13,021,324 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jun 2, 2026 | M | 32,282 | D | — | — | Class A Common Stock | 32,282 | 0 | D |
| Restricted Stock UnitsF2,F4 | — | Jun 3, 2026 | A | 25,146 | A | — | — | Class A Common Stock | 25,146 | 25,146 | D |
Explanation of responses
- F1Includes 12,096,702 shares of Class A Common Stock held by EW Healthcare Partners Acquisition Fund, L.P. ("Essex Stockholder") and 924,622 shares of Class A Common Stock held by White Pine Medical, LLC ("White Pine"). EW Healthcare Partners Acquisition Fund UGP, LLC ("General Partner") is the general partner of EW Healthcare Partners Acquisition Fund GP, L.P., which is the general partner of Essex Stockholder, which is the managing member of White Pine. Messrs. Sutter, Vainio, Eastman, and Barry (collectively, the "Managers") are the managers of the General Partner. The Managers disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- F3The RSUs vested on June 2, 2026.
- F4The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.